Showing results (161-170 of 289) with videos related to

Sort By:
Pageof 29
World Journal of Urology|November 2, 2005
Do early injections of bulking agents following radical prostatectomy improve early continence?T Schneider, H Sperling, R Rossi, et al.
Urologia Internationalis|June 12, 1999
Granulocyte-macrophage colony-stimulating factor and interferon-alpha 2B in patients with advanced renal cell carcinomaG Lümmen, H Sperling, H Luboldt, et al.
Der Urologe. Ausg. A|September 7, 2002
[Urothelial carcinoma. Role of G-protein coupled receptors in cell movement and proliferation]G Lümmen, H Sperling, T Schneider, et al.
The Journal of Urology|December 23, 2000
Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic urothelial cancer after failure of platinum chemotherapy: a phase 2 studyS Krege, V Rembrink, C Börgermann, et al.
Der Urologe. Ausg. A|March 3, 2011
[Exfoliative urine cytology in the treatment of bladder cancer]S Tschirdewahn, F Vom Dorp, H Rübben, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Comparison of tamsulosin efficacy in subgroups of patients with lower urinary tract symptomsM C Michel, L Mehlburger, H-U Bressel, et al.
European Urology|September 11, 1998
Tamsulosin: real life clinical experience in 19,365 patientsM C Michel, H U Bressel, L Mehlburger, et al.
The American Journal of Pathology|June 1, 1997
Improved prognosis assessment for patients with bladder carcinomaT Otto, A Bex, U Schmidt, et al.
The Journal of Urology|September 1, 1996
A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating ClinicsS Krege, G Giani, R Meyer, et al.
Der Urologe. Ausg. A|July 14, 2004
[Geriatric assessment. Is it significantly helpful in selection of elderly tumour patients for a difficult therapy?]S Krege, C Friedrich, G Lümmen, et al.
Pageof 29